ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Lapatinib Improves Outcome Of Advanced Breast Cancer

July 28, 2006

Institutions Required To Review For Bias under PHS Proposal

July 22, 1994

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

In Brief: Florida Osteopaths Join Medical Examiners, Nullify State’s Law Supporting Laetrile

January 18, 1985

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000